Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma

NCT00822120

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +20 more
Locations
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Springdale Rogers, Arkansas, United States
View all 423 locations
View Trial Details
Completed

Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies

NCT02795182

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • St Vincent's Hospital Darlinghurst, New South Wales, Australia
  • Concord Hospital Sydney, New South Wales, Australia
  • Royal Hobart Hospital Hobart, Tasmania, Australia
  • Monash Hospital Clayton, Victoria, Australia
View Trial Details
Completed

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze

NCT00634504

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +19 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Good Samaritan Hospital Los Angeles, California, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

NCT01239797

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Northwest Alabama Cancer Center, Pc Muscle Shoals, Alabama, United States
  • Acrc/Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Local Institution Berkeley, California, United States
  • Local Institution Burbank, California, United States
View all 216 locations
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions